Sheikh F G, Pahan K, Khan M, Barbosa E, Singh I
Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA.
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2961-6. doi: 10.1073/pnas.95.6.2961.
Peroxisomal disorders are lethal inherited diseases caused by either defects in peroxisome assembly or dysfunction of single or multiple enzymatic function(s). The peroxisomal matrix proteins are targeted to peroxisomes via the interaction of peroxisomal targeting signal sequences 1 and 2 (PTS1 or PTS2) with their respective cytosolic receptors. We have studied human skin fibroblast cell lines that have multiple peroxisomal dysfunctions with normal packaging of PTS1 and PTS2 signal-containing proteins but lack catalase in peroxisomes. To understand the defect in targeting of catalase to peroxisomes and the loss of multiple enzyme activities, we transfected the mutant cells with normal catalase modified to contain either PTS1 or PTS2 signal sequence. We demonstrate the integrity of these pathways by targeting catalase into peroxisomes via PTS1 or PTS2 pathways. Furthermore, restoration of peroxisomal functions by targeting catalase-SKL protein (a catalase fused to the PTS1 sequence) to peroxisomes indicates that loss of multiple functions may be due to their inactivation by H2O2 or other oxygen species in these catalase-negative peroxisomes. In addition to enzyme activities, targeting of catalase-SKL chimera to peroxisomes also corrected the in situ levels of fatty acids and plasmalogens in these mutant cell lines. In normal fibroblasts treated with aminotriazole to inhibit catalase, we found that peroxisomal functions were inhibited to the level found in mutant cells, an observation that supports the conclusion that multiple peroxisomal enzyme defects in these patients are caused by H2O2 toxicity in catalase-negative peroxisomes. Moreover, targeting of catalase to peroxisomes via PTS1 and PTS2 pathways in these mutant cell lines suggests that there is another pathway for catalase import into peroxisomes and that an abnormality in this pathway manifests as a peroxisomal disease.
过氧化物酶体疾病是由过氧化物酶体组装缺陷或单一或多种酶功能障碍引起的致死性遗传性疾病。过氧化物酶体基质蛋白通过过氧化物酶体靶向信号序列1和2(PTS1或PTS2)与其各自的胞质受体相互作用而靶向到过氧化物酶体。我们研究了人类皮肤成纤维细胞系,这些细胞系存在多种过氧化物酶体功能障碍,含PTS1和PTS2信号的蛋白质包装正常,但过氧化物酶体中缺乏过氧化氢酶。为了了解过氧化氢酶靶向过氧化物酶体的缺陷以及多种酶活性的丧失,我们用修饰为含有PTS1或PTS2信号序列的正常过氧化氢酶转染突变细胞。我们通过将过氧化氢酶通过PTS1或PTS2途径靶向到过氧化物酶体来证明这些途径的完整性。此外,通过将过氧化氢酶-SKL蛋白(与PTS1序列融合的过氧化氢酶)靶向到过氧化物酶体来恢复过氧化物酶体功能表明,多种功能的丧失可能是由于它们在这些过氧化氢酶阴性过氧化物酶体中被过氧化氢或其他氧物种灭活。除了酶活性外,将过氧化氢酶-SKL嵌合体靶向到过氧化物酶体还纠正了这些突变细胞系中脂肪酸和缩醛磷脂的原位水平。在用氨基三唑处理以抑制过氧化氢酶的正常成纤维细胞中,我们发现过氧化物酶体功能被抑制到在突变细胞中发现的水平,这一观察结果支持了这些患者中多种过氧化物酶体酶缺陷是由过氧化氢酶阴性过氧化物酶体中的过氧化氢毒性引起的这一结论。此外,在这些突变细胞系中通过PTS1和PTS2途径将过氧化氢酶靶向到过氧化物酶体表明,存在另一种过氧化氢酶导入过氧化物酶体的途径,并且该途径的异常表现为过氧化物酶体疾病。